0 Комментарии
0 Поделились
1162 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
- Войдите, чтобы отмечать, делиться и комментировать!
- Italy Peptide Receptor Radionuclide Therapy (Prrt) Market Estimated To Witness High Growth Owing To Increasing Incidence Of Neuroendocrine TumorsThe Italy Peptide Receptor Radionuclide Therapy (PRRT) market is estimated to be valued at US$ 591.83 Mn in 2023 and is expected to exhibit a CAGR of 8.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview:Peptide receptor radionuclide therapy or PRRT is a form of nuclear medicine therapy which is used for treating...0 Комментарии 0 Поделились 1080 Просмотры 0 предпросмотр
- Italy Peptide Receptor Radionuclide Therapy (PRRT) Market Is Driven By Growing Incidences Of Neuroendocrine TumorsPeptide receptor radionuclide therapy or PRRT is a type of cancer treatment that combines peptides tagged with radioactive elements or radiopharmaceuticals. PRRT involves the use of radiolabeled molecules that target receptors on cancer cells. These receptors overexpress on neuroendocrine tumors which enables the targeting of cancer cells. The radioisotopes delivered by the peptides allows for...0 Комментарии 0 Поделились 974 Просмотры 0 предпросмотр
- Neuroendocrine Tumor Treatment Market Growth Accelerated by Rising Prevalence of Neuroendocrine TumorsThe neuroendocrine tumor treatment market is witnessing significant growth owing to increasing prevalence of neuroendocrine tumors, globally. Neuroendocrine tumors arise from neuroendocrine cells and can originate in organs like lungs, pancreas or gastrointestinal tract. Treatment of neuroendocrine tumors involves the use of somatostatin analogs, targeted therapy drugs, chemotherapy and...0 Комментарии 0 Поделились 1161 Просмотры 0 предпросмотр
- Neuroendocrine Tumor Treatment Market Is Driven By Rising Prevalence Of Neuroendocrine TumorsGrowing demand in the market is attributed to rising incidence of neuroendocrine tumors and improved treatment options. With increasing risk factors like obesity, smoking, and consumption of alcohol and red meat, the occurrence of neuroendocrine tumors is rising globally. At the same time, significant advances have been made in imaging and other diagnostic techniques, facilitating early...0 Комментарии 0 Поделились 868 Просмотры 0 предпросмотр
- Neuroendocrine Tumors Therapeutics Market Overview 2023-29The global neuroendocrine tumors therapeutics market size was valued at USD 1.6 billion in 2022 and is poised to grow at a significant CAGR of 8.2% during the forecast period 2023-29. It also includes market size and projection estimations for each of the five major regions from 2023 to 2029. The research report includes historical data, trending features, and market growth estimates for the...0 Комментарии 0 Поделились 1343 Просмотры 0 предпросмотр
- Neuroendocrine Tumors Therapeutics Market Size, Share Analysis 2024The report "Neuroendocrine Tumors Therapeutics Market by Drug Class (Somatostatin Analogues,(Octreotide, Lanreotide, Pasireotide), Chemotherapeutics (Fluorouracil (5-FU), Doxorubicin (Adriamycin) or liposomal doxorubicin (Doxil), Streptozocin, Temozolomide (Temodar), Capecitabine (Xeloda), Dacarbazine (DTIC), Oxaliplatin (Eloxatin)), Targeted Therapeutics, (Sunitinib, Everolimus, Others)),...0 Комментарии 0 Поделились 931 Просмотры 0 предпросмотр
- Neuroendocrine Tumors Treatment Market Analysis, Size, Share, and Forecast 2031The Neuroendocrine Tumors Treatment Market in 2023 is US$ 3.37 billion, and is expected to reach US$ 8.47 billion by 2031 at a CAGR of 12.22%. FutureWise Research published a report that analyzes Neuroendocrine Tumors Treatment Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of the chain...0 Комментарии 0 Поделились 95 Просмотры 0 предпросмотр
- Pancreatic Neuroendocrine Tumors Market Research Report on Industry Dynamics With Growth Forecast To 2030Reports and Data have published a novel report on the global Pancreatic Neuroendocrine Tumors market that offers a comprehensive overview of the market and helps investors, and users understand market dynamics and make investment plans accordingly. The report offers details about market revenue growth, market size, drivers, restraints, limitations, growth opportunities, and top...0 Комментарии 0 Поделились 1432 Просмотры 0 предпросмотр
- Pancreatic Neuroendocrine Tumors Market Size, Key Factors, Major Players, Growth Strategies, Trends, Forecast Till 2030Reports and Data’s latest market analysis report, titled ‘Global Pancreatic Neuroendocrine Tumors Market – Forecast to 2030,’ is a comprehensive study of the Pancreatic Neuroendocrine Tumors industry and provides the targeted readers with vital data & information pertaining to the industry. The report comprises quantitative and qualitative research on the...0 Комментарии 0 Поделились 1675 Просмотры 0 предпросмотр
- Neuroendocrine Tumor Surgery Market Competitive Landscape, Growth Factors, Revenue Analysis, 2023–2030Reports and Data’s latest market analysis report, titled ‘Global Neuroendocrine Tumor Surgery Market – Forecast to 2030,’ is a comprehensive study of the Neuroendocrine Tumor Surgery industry and provides the targeted readers with vital data & information pertaining to the industry. The report comprises quantitative and qualitative research on the...0 Комментарии 0 Поделились 1424 Просмотры 0 предпросмотр
- Neuroendocrine Tumor Treatment Options And Their EfficacySurgery for NETsSurgery is often the first line of treatment for neuroendocrine tumors (NETs) that are localized to specific organs. The goal of surgery is to remove the entire tumor along with some of the healthy tissue surrounding it. For NETs located in the gastrointestinal tract or pancreas, the surgeon may perform an endoscopic or laparoscopic procedure to remove the tumor through small...0 Комментарии 0 Поделились 250 Просмотры 0 предпросмотр
Расширенные страницы